Skip to content
Library Home
Start Over
Research Databases
E-Journals
Course Reserves
Library Home
Login to library account
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Language
Library Catalog
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Find
Advanced Search
|
Browse
|
Search Tips
Frontiers in Clinical Drug Res...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Frontiers in Clinical Drug Research. Volume 4, Diabetes and Obesity
Saved in:
Bibliographic Details
Main Author:
Atta-ur-Rehman
Format:
eBook
Language:
English
Published:
Sharjah :
Bentham Science Publishers,
2019.
Series:
Frontiers in Clinical Drug Research - Diabetes and Obesity Ser.
Subjects:
Diabetes.
Diabetes
>
Treatment.
Obesity.
Diabetes
Diabetes
>
Treatment
Obesity
Online Access:
Click for online access
Holdings
Description
Table of Contents
Similar Items
Staff View
Table of Contents:
Cover; Title; Biblography; End User License Agreement; Contents; Preface; List of Contributors; Pharmacologic Obesity Treatment
Emphasis on Efficacy and Cardiometabolic Markers; Fariha Salman1, Ivan Gerling2 and Helmut O. Steinberg*, 2; INTRODUCTION; Weight-Loss Drug Decreasing Food Absorption; Weight-Loss Drugs Decreasing Food Intake; Combination of Topiramate and Phentermine; Combination of Naltrexone and Bupropion; Liraglutide; Summary; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES
Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic ComplicationsJessica Felton1 and Jean-Pierre Raufman2,*; INTRODUCTION AND OVERVIEW; Bile Acid Synthesis & Circulation; Bile Acid Feedback Mechanisms; TAKEDA G PROTEIN-COUPLED RECEPTOR-5 (TGR5); TGR5 & Immunity; TGR5 in the Liver and Gallbladder; TGR5 & Thyroid Hormone Activation; GLUCAGON-LIKE PEPTIDE 1 (GLP-1); Physiology of GLP-1; Effects of GLP-1; Pathophysiology of GLP-1; THE ROLE OF TGR5 IN GLP-1 SECRETION; THE ROLE OF FXR IN GLUCOSE HOMEOSTASIS
MANIPULATING THE BILE ACID POOL FOR GLUCOSE HOMEOSTASISBILE ACIDS & GLP-1 AFTER BARIATRIC SURGERY; Glucose Homeostasis following Gastric Bypass Surgery; Increased Bile Acid Levels after Gastric Bypass Surgery; PHARMACOLOGY; GLP-1 Agonists; DPP4 Inhibitors; TGR5 Agonists; FUTURE DIRECTIONS; CONCLUSIONS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Sodium-Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus: The 'New Kids on the Block' in the Era of Evidence-based Medicine; Cheow Peng Ooi1,*, Norlaila Mustafa2, Nor Azmi Kamaruddin2 and Munn Sann Lye3
INTRODUCTIONEpidemiology; Pathophysiology of T2DM; Glycaemic Control; NEW TREATMENT OPTION; Role of SGLTs in Glucose Homoeostasis; Drug Development Status of SGLT Inhibitors; Efficacy of SGLT2 Inhibitors; Safety of SGLT2 Inhibitors; Post-regulatory Approval and Long-term Safety Concerns; EVIDENCE-BASED MEDICINE; Evidence-based Medicine at the Crossroads; Dilemmas in Evidence-based Medicine; Restricted View of Evidence; Limitations of Clinical Trials; Misleading Results; Issues in Translating RCTs to the Clinical Care Arena; The Efficacy-Efficiency Gap; Secondary Research of Evidence Synthesis
Similar Items
Frontiers in clinical drug research. Volume 3, Diabetes and obesity
Published: (2016)
Frontiers in clinical drug research - diabetes and obesity, volume 2.
Published: (2016)
Obesity and diabetes : scientific advances and best practice
Published: (2021)
Management of Diabetes Mellitus : a Guide to the Pattern Approach
by: Guthrie, Diana W.
Published: (2009)
Behavioral diabetes : social ecological perspectives for pediatric and adult populations
Published: (2020)